Avvinity Chief Scientific Officer presents at ELRIG Webinar

ELRIG logo

Dr Chris Pickford, Avvinity’s Chief Scientific Officer, presented at the 2020 ELRIG webinar “Next Generation Biologics and the Future of Cancer Therapy” recently.  Chris described the work undertaken to develop the company’s proprietary Alphamer© technology and the plans for their use as novel immunotherapeutics to treat cancer.

More information about this event and ELRIG can be found at this link.

Back to news